Vanguard Group Inc Kiromic Biopharma, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.87 $74,107 - $247,974	-285,028 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.6 - $1.82 $6,657 - $20,192	-11,095 Reduced 3.75%	285,028 $244,000
Q4 2021 Feb 14, 2022	BUY	$1.53 - $3.12 $1,277 - $2,605	835 Added 0.28%	296,123 $453,000
Q3 2021 Nov 12, 2021	BUY	$2.69 - $4.94 $473,396 - $869,360	175,984 Added 147.51%	295,288 $906,000
Q2 2021 Aug 13, 2021	BUY	$4.81 - $10.34 $573,852 - $1.23 Million	119,304 New	119,304 $574,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.